Skip to content

Cash Benefits and Reproductive/Perinatal Health

Cash Benefits and Reproductive/Perinatal Health

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05782660
Enrollment
3615
Registered
2023-03-23
Start date
2020-07-27
Completion date
2025-08-31
Last updated
2024-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maternal Care Patterns, Miscarriage, Pregnancy Related

Brief summary

During the first two years of the COVID-19 pandemic, the City of Chelsea, Massachusetts held a lottery to allocate cash benefits to its residents for ten months. Using data from the Chelsea Eats program, the investigators propose to study the impact of the cash benefit on reproductive and perinatal health.

Interventions

Spending from the cards was not restricted to food but could be spent on anything and anywhere Visa was accepted. The debit cards were credited with the first payment on November 18th, 2020 and the second payment on December 18th, 2020. The program continued with monthly credits through August 2021.

No monthly cash benefit.

Sponsors

Brigham and Women's Hospital
CollaboratorOTHER
Harvard Medical School (HMS and HSDM)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 44 Years
Healthy volunteers
No

Inclusion criteria

* Resident of Chelsea, Massachusetts * Household income at or below 30% of the U.S. Department of Housing and Urban Development's Area Median Income * Childbearing age

Exclusion criteria

* See inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Pregnancy20 monthsPregnancies will be identified using the electronic health record, documented with a positive urine or blood pregnancy test, ultrasound, and/or diagnosis codes over the 10 months of the trial; because pregnancy without delivery is the primary outcome for our main analysis, the investigators will then determine whether each pregnancy did or did not result in a live childbirth delivered vaginally or via Cesarean section, which can occur after the 10 months of the trial

Secondary

MeasureTime frameDescription
Abortion20 monthsProcedural abortions and prescriptions for medical abortions, focusing specifically on induced abortions
Prenatal vitamin prescriptions prior to pregnancy10 monthsNew use of prenatal vitamins, including multivitamins, as prescribed or documented in the electronic health record
Miscarriage20 monthsMiscarriages presenting to the health care setting identified using diagnosis codes and documentation within clinical notes
Number and timing of prenatal visits before delivery20 monthsPrenatal visits before delivery and initiation during first trimester
Composite of birth outcomes20 monthsFollowing McConnell et al., this outcome is a composite of at least one of: low birth weight, preterm birth, small for gestational age, or perinatal mortality
Contraception10 monthsUtilization of long-acting reversible contraceptive methods (intrauterine devices or implants) and prescriptions for hormonal birth control methods (pill, patch, ring)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026